The clinical presentation and management of carcinoid heart disease

被引：33

作者：

Dobson, R. ^{[1
,5
]}

Burgess, M. I. ^{[1
,2
]}

Pritchard, D. M. ^{[3
,4
]}

Cuthbertson, D. J. ^{[1
,5
]}

机构：

[1] Aintree Univ Hosp NHS Fdn Trust, Neuroendocrine Tumour Grp, Liverpool L9 7AL, Merseyside, England

[2] Aintree Univ Hosp NHS Fdn Trust, Dept Cardiol, Liverpool L9 7AL, Merseyside, England

[3] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3GE, Merseyside, England

[4] Royal Liverpool Univ Hosp, Neuroendocrine Tumour Grp, Liverpool L7 8XP, Merseyside, England

[5] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3GA, Merseyside, England

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 173卷 / 01期

关键词：

Carcinoid heart disease; Valve surgery; Management; ENETS CONSENSUS GUIDELINES; BRAIN NATRIURETIC PEPTIDE; NEUROENDOCRINE-TUMORS; CARDIAC-SURGERY; VALVE-REPLACEMENT; HEPATIC RESECTION; GROWTH-FACTOR; ECHOCARDIOGRAPHY; DIAGNOSIS; OUTCOMES;

D O I：

10.1016/j.ijcard.2014.02.037

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Carcinoid heart disease is a major cause of morbidity and mortality in patients with metastatic neuroendocrine tumours (NETs). Although cases of carcinoid syndrome and severe carcinoid heart disease requiring urgent intervention are well described, many patients with significant carcinoid heart disease may have insidious symptoms or even be asymptomatic. As haemodynamically significant carcinoid heart disease may be clinically silent, specific and individualised considerations must be made as to the most appropriate clinical criteria and time point at which surgical valve replacement should be undertaken in patients with carcinoid heart disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：29 / 32

页数：4

共 50 条

[1] Carcinoid heart disease: Presentation, diagnosis, and management
Fox, DJ
Khattar, RS
HEART, 2004, 90 (10) : 1224 - 1228
[2] UNIQUE PRESENTATION OF CARCINOID HEART DISEASE
Seok, Kieun
Akinsiku, Oladele
Chen, Allan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2882 - 2882
[3] Clinical presentation and management of carcinoid tumors
Kulke, Matthew H.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (03) : 433 - +
[4] Management of carcinoid heart disease
Hack, Madelaine
Bhamidipati, Castigliano M.
CURRENT PROBLEMS IN CANCER, 2024, 52
[5] Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management
Jin, Chengyue
Sharma, Ajay Nair
Thevakumar, Balasingam
Majid, Muhammad
Al Chalaby, Shahad
Takahashi, Nene
Tanious, Ashraf
Arockiam, Aro Daniela
Beri, Neil
Amsterdam, Ezra A.
CARDIOLOGY, 2021, 146 (01) : 65 - 73
[6] Carcinoid Heart Disease - A Review of Pathophysiology, Clinical Manifestations, Diagnosis and Management
Ghanta, Sai Nikhila
Vallurupalli, Srikanth
CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
[7] Carcinoid heart disease: Diagnosis and management
Luis, Sushil A.
Pellikka, Patricia A.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (01) : 149 - 158
[8] Carcinoid Heart Disease Associated with Primary Ovarian Carcinoid Tumor: A Rare Presentation
Ahmad, Rawaha
Loke, Ian
Saifullah, Fizza
Zafar, Hafsa
Abbasi, Saddam Hussain
HEART VIEWS, 2024, 25 (02): : 106 - 109
[9] Surgical Management of Carcinoid Heart Valve Disease
Castillo, Javier G.
Milla, Federico
Adams, David H.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2012, 24 (04) : 254 - 260
[10] Multidisciplinary team management of carcinoid heart disease
Steeds, Richard P.
Sagar, Vandana
Shetty, Shishir
Oelofse, Tessa
Singh, Harjot
Ahmad, Raheel
Bradley, Elizabeth
Moore, Rachel
Vickrage, Suzanne
Smith, Stacey
Yim, Ivan
Elhassan, Yasir S.
Venkataraman, Hema
Ayuk, John
Rooney, Stephen
Shah, Tahir
ENDOCRINE CONNECTIONS, 2019, 8 (12) : R184 - R199

← 1 2 3 4 5 →